INOV - Inovalon Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
18.90
+0.23 (+1.23%)
At close: 4:00PM EDT

18.90 0.00 (0.00%)
After hours: 6:00PM EDT

Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close18.67
Open18.53
Bid18.89 x 800
Ask18.90 x 1400
Day's Range18.01 - 18.93
52 Week Range13.39 - 22.99
Volume230,218
Avg. Volume465,152
Market Cap2.937B
Beta (5Y Monthly)0.69
PE Ratio (TTM)198.95
EPS (TTM)0.09
Earnings DateJul 29, 2020 - Aug 03, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-43% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Benzinga's Top Upgrades, Downgrades For July 14, 2020

    Upgrades * For Hanesbrands Inc (NYSE: HBI), Credit Suisse upgraded the stock from Neutral to Outperform. For the first quarter, Hanesbrands had an EPS of $0.05, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $17.09 and a 52-week-low of $6.96. Hanesbrands's stock last closed at $11.46 per share. * B of A Securities changed the rating for Laboratory Corp of America Holdings (NYSE: LH) from Neutral to Buy. Laboratory Corp earned $2.37 in the first quarter, compared to $2.62 in the year-ago quarter. The stock has a 52-week-high of $196.36 and a 52-week-low of $98.02. Laboratory Corp's stock last closed at $178.31 per share. * B of A Securities changed the rating for Quest Diagnostics Inc (NYSE: DGX) from Neutral to Buy. For the first quarter, Quest Diagnostics had an EPS of $0.94, compared to year-ago quarter EPS of $1.40. The stock has a 52-week-high of $125.00 and a 52-week-low of $73.02. Quest Diagnostics's stock last closed at $119.07 per share. * CLSA changed the rating for Honda Motor Co Ltd (NYSE: HMC) from Underperform to Buy. For the fourth quarter, Honda Motor Co had an EPS of ($0.16), compared to year-ago quarter EPS of ($0.07). The stock has a 52-week-high of $29.44 and a 52-week-low of $19.38. Honda Motor Co's stock last closed at $25.82 per share. * BMO Capital upgraded the stock for Harley-Davidson Inc (NYSE: HOG) from Market Perform to Outperform. In the first quarter, Harley-Davidson showed an EPS of $0.51, compared to $0.98 from the year-ago quarter. The stock has a 52-week-high of $40.89 and a 52-week-low of $14.31. Harley-Davidson's stock last closed at $25.95 per share. * For Matador Resources Co (NYSE: MTDR), MKM Partners upgraded the stock from Neutral to Buy. Matador Resources earned $0.20 in the first quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $19.94 and a 52-week-low of $1.11. Matador Resources's stock last closed at $7.76 per share. Downgrades * Northcoast Research downgraded the stock for Lyft Inc (NASDAQ: LYFT) from Buy to Neutral. Lyft earned ($0.32) in the first quarter, compared to ($9.02) in the year-ago quarter. The stock has a 52-week-high of $68.33 and a 52-week-low of $14.56. Lyft's stock last closed at $28.81 per share. * B. Riley FBR changed the rating for Benefytt Technologies Inc (NASDAQ: BFYT) from Buy to Neutral. The stock has a 52-week-high of $30.85 and a 52-week-low of $15.60. Benefytt Technologies's stock last closed at $30.80 per share. * For ManpowerGroup Inc (NYSE: MAN), Goldman Sachs downgraded the stock from Neutral to Sell. For the first quarter, ManpowerGroup had an EPS of $0.82, compared to year-ago quarter EPS of $0.88. The stock has a 52-week-high of $100.99 and a 52-week-low of $49.57. ManpowerGroup's stock last closed at $70.34 per share. * For Royal Caribbean Cruises Ltd (NYSE: RCL), Macquarie downgraded the stock from Outperform to Neutral. Royal Caribbean Cruises earned ($1.48) in the first quarter, compared to $1.31 in the year-ago quarter. The stock has a 52-week-high of $135.31 and a 52-week-low of $19.25. Royal Caribbean Cruises's stock last closed at $49.60 per share. * Macquarie changed the rating for Norwegian Cruise Line Holdings Ltd (NYSE: NCLH) from Outperform to Neutral. Norwegian Cruise Line earned ($0.99) in the first quarter, compared to $0.83 in the year-ago quarter. The stock has a 52-week-high of $59.78 and a 52-week-low of $7.03. Norwegian Cruise Line's stock last closed at $15.62 per share. * UBS downgraded the stock for Spotify Technology SA (NYSE: SPOT) from Buy to Sell. For the first quarter, Spotify Technology had an EPS of ($0.22), compared to year-ago quarter EPS of ($0.90). The stock has a 52-week-high of $285.40 and a 52-week-low of $109.18. Spotify Technology's stock last closed at $261.11 per share. * For EverQuote Inc (NASDAQ: EVER), B of A Securities downgraded the stock from Neutral to Underperform. For the first quarter, EverQuote had an EPS of ($0.05), compared to year-ago quarter EPS of ($0.17). The stock has a 52-week-high of $63.44 and a 52-week-low of $13.01. EverQuote's stock last closed at $58.19 per share. * UBS changed the rating for Netflix Inc (NASDAQ: NFLX) from Buy to Neutral. In the first quarter, Netflix showed an EPS of $1.57, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $575.37 and a 52-week-low of $252.28. Netflix's stock last closed at $525.50 per share. Initiations * Citigroup initiated coverage on Change Healthcare Inc (NASDAQ: CHNG) with a Buy rating. The price target for Change Healthcare is set at $15.00. Change Healthcare earned $0.42 in the fourth quarter, compared to $0.50 in the year-ago quarter. The stock has a 52-week-high of $17.57 and a 52-week-low of $6.18. Change Healthcare's stock last closed at $10.00 per share. * With a rating of Neutral, Citigroup initiated coverage on Inovalon Holdings Inc (NASDAQ: INOV). The price target is set at $20.00 for Inovalon Holdings. Inovalon Holdings earned $0.11 in the first quarter, compared to $0.10 in the year-ago quarter. The stock has a 52-week-high of $22.99 and a 52-week-low of $13.39. Inovalon Holdings's stock last closed at $18.67 per share. * With a rating of Outperform, Oppenheimer initiated coverage on GrowGeneration Corp (NASDAQ: GRWG). The price target is set at $15.00 for GrowGeneration. The stock has a 52-week-high of $7.82 and a 52-week-low of $2.62. GrowGeneration's stock last closed at $6.83 per share. * Goldman Sachs initiated coverage on Euronet Worldwide Inc (NASDAQ: EEFT) with a Neutral rating. The price target for Euronet Worldwide is set at $101.00. In the first quarter, Euronet Worldwide showed an EPS of $0.55, compared to $0.85 from the year-ago quarter. The stock has a 52-week-high of $170.94 and a 52-week-low of $61.27. Euronet Worldwide's stock last closed at $95.61 per share. * With a rating of Sell, Goldman Sachs initiated coverage on The Western Union Co (NYSE: WU). The price target is set at $22.00 for The Western Union. For the first quarter, The Western Union had an EPS of $0.44, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $28.45 and a 52-week-low of $17.39. The Western Union's stock last closed at $21.48 per share. * With a rating of Sell, Goldman Sachs initiated coverage on Paychex Inc (NASDAQ: PAYX). The price target is set at $64.00 for Paychex. For the fourth quarter, Paychex had an EPS of $0.61, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of $90.53 and a 52-week-low of $47.87. Paychex's stock last closed at $71.63 per share. * With a rating of Sell, Goldman Sachs initiated coverage on Automatic Data Processing Inc (NASDAQ: ADP). The price target is set at $146.00 for Automatic Data Processing. Automatic Data Processing earned $1.92 in the third quarter, compared to $1.77 in the year-ago quarter. The stock has a 52-week-high of $182.32 and a 52-week-low of $103.11. Automatic Data Processing's stock last closed at $145.48 per share. * Goldman Sachs initiated coverage on WEX Inc (NYSE: WEX) with a Neutral rating. The price target for WEX is set at $164.00. WEX earned $1.81 in the first quarter, compared to $1.72 in the year-ago quarter. The stock has a 52-week-high of $236.51 and a 52-week-low of $71.12. WEX's stock last closed at $152.86 per share. * Goldman Sachs initiated coverage on Fleetcor Technologies Inc (NYSE: FLT) with a Buy rating. The price target for Fleetcor Technologies is set at $301.00. For the first quarter, Fleetcor Technologies had an EPS of $3.00, compared to year-ago quarter EPS of $2.67. The stock has a 52-week-high of $329.85 and a 52-week-low of $168.51. Fleetcor Technologies's stock last closed at $248.06 per share. * Goldman Sachs initiated coverage on Open Lending Corp (NASDAQ: LPRO) with a Buy rating. The price target for Open Lending is set at $20.00. The stock has a 52-week-high of $16.36 and a 52-week-low of $12.70. Open Lending's stock last closed at $15.67 per share. * Goldman Sachs initiated coverage on Fidelity National Information Services Inc (NYSE: FIS) with a Buy rating. The price target for Fidelity National Info is set at $164.00. For the first quarter, Fidelity National Info had an EPS of $1.28, compared to year-ago quarter EPS of $1.64. The stock has a 52-week-high of $158.21 and a 52-week-low of $91.68. Fidelity National Info's stock last closed at $135.47 per share. * With a rating of Buy, Goldman Sachs initiated coverage on Mastercard Inc (NYSE: MA). The price target is set at $364.00 for Mastercard. For the first quarter, Mastercard had an EPS of $1.83, compared to year-ago quarter EPS of $1.78. The stock has a 52-week-high of $347.25 and a 52-week-low of $199.99. Mastercard's stock last closed at $290.14 per share. * Goldman Sachs initiated coverage on Visa Inc (NYSE: V) with a Buy rating. The price target for Visa is set at $223.00. In the second quarter, Visa showed an EPS of $1.39, compared to $1.31 from the year-ago quarter. The stock has a 52-week-high of $214.17 and a 52-week-low of $133.93. Visa's stock last closed at $189.08 per share. * With a rating of Buy, Jefferies initiated coverage on AudioCodes Ltd (NASDAQ: AUDC). The price target is set at $40.00 for AudioCodes. AudioCodes earned $0.25 in the first quarter, compared to $0.18 in the year-ago quarter. The stock has a 52-week-high of $40.06 and a 52-week-low of $9.00. AudioCodes's stock last closed at $31.25 per share. * Goldman Sachs initiated coverage on Square Inc (NYSE: SQ) with a Neutral rating. The price target for Square is set at $133.00. Square earned ($0.02) in the first quarter, compared to $0.11 in the year-ago quarter. The stock has a 52-week-high of $133.81 and a 52-week-low of $32.33. Square's stock last closed at $118.66 per share. * BTIG initiated coverage on Genetron Holdings Ltd (NASDAQ: GTH) with a Buy rating. The price target for Genetron Holdings is set at $20.00. * Cowen & Co. initiated coverage on Repare Therapeutics Inc (NASDAQ: RPTX) with an Outperform rating. * SunTrust Robinson Humphrey initiated coverage on CRISPR Therapeutics AG (NASDAQ: CRSP) with a Buy rating. The price target for CRISPR Therapeutics is set at $140.00. In the first quarter, CRISPR Therapeutics showed an EPS of ($1.15), compared to ($0.93) from the year-ago quarter. The stock has a 52-week-high of $97.82 and a 52-week-low of $32.30. CRISPR Therapeutics's stock last closed at $86.23 per share. * Jefferies initiated coverage on Forma Therapeutics Holdings Inc (NASDAQ: FMTX) with a Buy rating. The price target for Forma Therapeutics Hldgs is set at $54.00. * Piper Sandler initiated coverage on Repare Therapeutics Inc (NASDAQ: RPTX) with an Overweight rating. The price target for Repare Therapeutics is set at $40.00. * With a rating of Outperform, Credit Suisse initiated coverage on Forma Therapeutics Holdings Inc (NASDAQ: FMTX). The price target is set at $64.00 for Forma Therapeutics Hldgs.See more from Benzinga * ROCE Insights For General Electric * Recap: Barnes & Noble Education Q4 Earnings * Recap: Wipro Q1 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • GlobeNewswire

    Inovalon Announces Second Quarter 2020 Earnings Conference Call

    BOWIE, Md., July 14, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold a conference call for investors on Wednesday, July 29, 2020, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the Company’s second quarter 2020 financial results, which will be announced via press release after the close of market trading.The conference call can be accessed by dialing (855) 783-2604, conference ID 7199074; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon’s website at www.inovalon.com.About InovalonInovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than 994,000 physicians, 558,000 clinical facilities, 315 million Americans, and 55 billion medical events. For more information, visit www.inovalon.com.Contact:Kim E. Collins Senior Vice President, Corporate Communications kcollins@inovalon.com 301-809-4000 x1473Hulus Alpay Vice President, Investor Relations halpay@inovalon.com 301-809-4000 x1237

  • Inovalon Holdings Inc (INOV): Hedge Funds Taking Some Chips Off The Table
    Insider Monkey

    Inovalon Holdings Inc (INOV): Hedge Funds Taking Some Chips Off The Table

    In this article you are going to find out whether hedge funds think Inovalon Holdings Inc (NASDAQ:INOV) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks […]

  • GlobeNewswire

    Inovalon ONE® Platform Selected by Cardinal Health

    Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a five-year engagement with Cardinal Health, Inc. (CAH), a global integrated healthcare services and products company, to provide a configuration of Inovalon’s ScriptMed® Cloud. The platform will be used to support Cardinal Health’s durable medical equipment (DME) and medical supplies business, which works to provide superior care in the home.

  • GlobeNewswire

    Priority Health Selects The Inovalon ONE® Platform

    Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a multi-year engagement with Priority Health, a leading Michigan health plan with more than one million members, to provide a configuration of the Inovalon ONE® Platform in support of superior member insights and economic performance for its commercial and Medicare Advantage memberships. Under this engagement, Inovalon will implement Modules of the Inovalon ONE® Platform empowering healthcare ecosystem connectivity, data integration, clinical data extraction, natural language processing, predictive analytics, data visualization, and a number of additional capabilities within an integrated offering for Priority Health.

  • GlobeNewswire

    Inovalon’s 2020 Annual Meeting of Stockholders Will be Virtual Only

    Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold its 2020 annual meeting of stockholders in a virtual-only format due to health and safety concerns related to the ongoing COVID-19 pandemic and to comply with federal, state, and local restrictions on public gatherings. Stockholders will not be able to attend the annual meeting in person. There is no change to the items of business to be addressed at the annual meeting, which are described in Inovalon’s proxy materials previously filed with the Securities and Exchange Commission.

  • Moody's

    Inovalon Holdings, Inc. -- Moody's announces completion of a periodic review of ratings of Inovalon Holdings, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Inovalon Holdings, Inc. New York, May 27, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Inovalon Holdings, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • GlobeNewswire

    Inovalon Launches InfectionWatch™ For The Provider Marketplace

    BOWIE, Md., May 27, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced today the launch of.

  • GlobeNewswire

    Inovalon Launches Cloud-Based Consumer Health Gateway Module Empowering Accelerated Patient Data Access and Healthcare Organization Compliance With The Interoperability Rule

    Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the launch of its Consumer Health Gateway™, a Fast Healthcare Interoperability Resources (FHIR®)-based solution Module of the Inovalon ONE® Platform that enables health plans with Medicare Advantage, Commercial ACA and Medicaid/CHIP insurance products to easily and efficiently comply with the new Patient Access Application Program Interface (API) requirement of the 21st Century Cures Act, effective July 1, 2021, while also paving the way for applications empowering consumers to access and benefit from their own personal healthcare data in real time. Under the 21st Century Cures Act, organizations engaged in supporting and providing care within the United States are required to support increasing interoperability and access to patient-level data as the Centers for Medicare and Medicaid (CMS) focuses on empowering improved quality and efficiency of patient care.

  • GlobeNewswire

    Inovalon Launches Population Health Insights: COVID-19 Compass Dashboard

    BOWIE, Md., May 19, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the availability of its new.

  • GlobeNewswire

    Inovalon To Participate in the SunTrust Robinson Humphrey Virtual Meeting Series

    BOWIE, Md., May 18, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D.,.

  • Thomson Reuters StreetEvents

    Edited Transcript of INOV earnings conference call or presentation 29-Apr-20 9:00pm GMT

    Q1 2020 Inovalon Holdings Inc Earnings Call

  • Inovalon Holdings (INOV) Q1 2020 Earnings Call Transcript
    Motley Fool

    Inovalon Holdings (INOV) Q1 2020 Earnings Call Transcript

    This is Kim Collins, senior vice president of communications at Inovalon. The press release announcing our financial results for the first quarter of 2020 was distributed this afternoon, and a replay of today's call will be available shortly, posted on the investor relations page on Inovalon's website.

  • GlobeNewswire

    Inovalon Reports First Quarter 2020 Results

    First Quarter 2020 Highlights Q1 revenue of $154.2 million, up 6.0% year-over-yearQ1 Subscription-based platform revenue of $137.1 million, up 13.1% year-over-year, equating to.

  • Should Inovalon Holdings, Inc.’s (NASDAQ:INOV) Weak Investment Returns Worry You?
    Simply Wall St.

    Should Inovalon Holdings, Inc.’s (NASDAQ:INOV) Weak Investment Returns Worry You?

    Today we are going to look at Inovalon Holdings, Inc. (NASDAQ:INOV) to see whether it might be an attractive...

  • GlobeNewswire

    Inovalon Announces First Quarter 2020 Earnings Conference Call

    BOWIE, Md., April 15, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold a.

  • Another 270,000 apply for unemployment benefits in D.C., Maryland and Virginia
    American City Business Journals

    Another 270,000 apply for unemployment benefits in D.C., Maryland and Virginia

    Another 6.6 million Americans — including more than 270,000 in D.C., Maryland and Virginia — filed initial U.S. unemployment claims last week, extending the economic crisis related to the coronavirus pandemic.

  • Hedge Funds Have Never Been This Bullish On Inovalon Holdings Inc (INOV)
    Insider Monkey

    Hedge Funds Have Never Been This Bullish On Inovalon Holdings Inc (INOV)

    We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]

  • GlobeNewswire

    Inovalon Launches Telehealth Configuration of The Inovalon ONE® Platform  

    Inovalon (INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it has launched a telehealth configuration of the Inovalon ONE® Platform, empowering virtual data-driven visits with clinicians for clients across the country. The implementation of telehealth capabilities within Inovalon ONE® Platform brings the power of advanced analytics and data-driven encounters to the telehealth marketplace.

  • Avalere Health Partners With Leading Registry And Analytics Company, Corrona LLC, To Combine Economic And Clinical Outcomes Data For Autoimmune Diseases
    PR Newswire

    Avalere Health Partners With Leading Registry And Analytics Company, Corrona LLC, To Combine Economic And Clinical Outcomes Data For Autoimmune Diseases

    Avalere, an Inovalon company specializing in healthcare research and strategic advisory services, has entered into a collaboration with Corrona, a leader in real-world evidence generation in autoimmune diseases through its independent registry platform. Under the agreement, Avalere will utilize data from Inovalon's large scale, real-world MORE2 Registry® dataset along with data elements from Corrona's clinical registries. The MORE2 Registry® dataset contains primary source, de-identified, and longitudinally matched medical, pharmacy, and laboratory data on more than 314 million unique patients spanning 53 billion medical events and more than 988,000 physicians across Medicare, Medicaid, and commercially insured markets. Corrona collects deep clinical data on validated physician assessments used in pivotal phase 3 trials as well as disease-specific patient reported outcomes, yielding a comprehensive longitudinal dataset that stands apart from datasets derived from electronic medical records, claims, or patient surveys. Data collected from over 500 sites in the US, Canada, and Japan make Corrona the largest network of real-world investigators contributing prospective data for patients with autoimmune conditions. Combined, the datasets will offer a complete and highly differentiated picture of patients with autoimmune conditions, enabling the real-world and longitudinal assessment of the dynamics between patient demographics, clinical characteristics, functional status, patient-reported outcome measures, laboratory values, healthcare resource utilization, and economic outcomes.

  • Investors Who Bought Inovalon Holdings (NASDAQ:INOV) Shares Five Years Ago Are Now Down 55%
    Simply Wall St.

    Investors Who Bought Inovalon Holdings (NASDAQ:INOV) Shares Five Years Ago Are Now Down 55%

    Statistically speaking, long term investing is a profitable endeavour. But along the way some stocks are going to...

  • GlobeNewswire

    ABILITY Network Announces Integrated Workflow Collaboration with PracticeSuite

    ABILITY® Network, an Inovalon company (INOV) a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a collaboration agreement with PracticeSuite, a cloud-based healthcare technology solution and service provider for independent practices, to improve the efficiency and accuracy of payer claims management. The ABILITY EASE® All-Payer solution, a cloud-based application available through the ABILITY provider platform modules of the Inovalon ONE® Platform, is now accessible to the more than 57,000 medical professionals served by PracticeSuite.

  • GlobeNewswire

    Inovalon to Participate at the SunTrust Robinson Humphrey Technology, Internet and Services Conference

    BOWIE, Md., March 03, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D.,.

  • Weekly CEO Buys Highlight
    GuruFocus.com

    Weekly CEO Buys Highlight

    Details the CEO buys for the following companies: GEO Group, Bunge, Magnolia Oil & Gas, American Assets Trust and Inovalon Holdings Continue reading...

  • GlobeNewswire

    Inovalon to Present at Morgan Stanley Technology, Media & Telecom Conference

    BOWIE, Md., Feb. 24, 2020 -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D.,.